[NBIX] QoQ Quarter Result on 30-Sep-2018 [#Q3]

Stock
[NBIX] Neurocrine Biosciences, Inc.
Announcement Date
05-Nov-2018
Financial Year
2018
Quarter
30-Sep-2018 [#Q3]
Profit Trend
QoQ- 958.52%
YoY- 556.31%
Quarter Report
NBIX's Result
NBIX's Financial Summary
View:
Show?
Quarter Result
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
Revenue 183,580 138,403 131,492 151,757 96,905 71,086 94,517 55.86%
PBT 52,091 -102,594 18,808 50,764 -5,913 -41,818 6,894 286.48%
Tax 753 -479 730 7,672 7,591 7,504 6,686 -76.77%
NP 51,338 -102,115 18,078 50,764 -5,913 -41,818 6,894 282.74%
Tax Rate -1.45% - -3.88% -15.11% - - -96.98% -
Total Cost 132,242 240,518 113,414 100,993 102,818 112,904 87,623 31.67%
Ratio Analysis
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
NP Margin 27.96 -73.78 13.75 33.45 -6.10 -58.83 7.29 145.62%
Per Share
30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 CAGR
EPS 0.56 -1.12 0.20 0.56 -0.07 -0.47 0.08 267.23%
EPS Diluted 0.54 -1.12 0.19 0.52 -0.07 -0.47 0.07 291.88%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.